Bank of America
IMNN icon

Bank of America’s Imunon IMNN Stock Holding History

Bank of America’s Portfolio IMNN Stock Details IMNN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Hold
0
– -$2K – 7290
2014
Q4 		– Hold
0
– – – 7483
2014
Q3 		– Hold
0
– – – 7607
2014
Q2 		– Hold
0
– – – 7749
2014
Q1 		– Sell
-1
Closed -$10.4K – 7462
2013
Q4 		$10K Buy
+1
New +$12K ﹤0.01% 7284
2013
Q3 		– Hold
0
– -$4K – 7945
2013
Q2 		– Hold
0
– – – 7399

Other funds holding IMNN

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
RCA
Riverview Capital Advisers Boston, Massachusetts $300M AUM 10.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Bank of America's IMNN Position: Q1 2026 in Review

Bank of America sold out of Imunon (IMNN) in Q1 2026, closing a stake of 27 shares — an estimated $103 sold.

Bank of America first reported a position in IMNN in Q2 2013 and held it in 33 quarters. The position peaked at $262K in Q2 2013. 19 funds tracked by Wall St. Rank hold IMNN as of Q1 2026.

  • Bank of America reported no remaining Imunon position as of Q1 2026 after selling out during the quarter.
  • Bank of America sold 27 Imunon shares in Q1 2026, an estimated $103.
  • Bank of America first reported a position in Imunon in Q2 2013 and held it in 33 quarters.
  • Bank of America's Imunon position peaked at $262K in Q2 2013.
  • 19 funds tracked by Wall St. Rank held Imunon as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.